Your browser doesn't support javascript.
loading
A Phase 2 Study of Capmatinib in Patients With MET-Altered Lung Cancer Previously Treated With a MET Inhibitor.
Dagogo-Jack, Ibiayi; Moonsamy, Philicia; Gainor, Justin F; Lennerz, Jochen K; Piotrowska, Zofia; Lin, Jessica J; Lennes, Inga T; Sequist, Lecia V; Shaw, Alice T; Goodwin, Kelly; Stevens, Sara E; Do, Andrew; Digumarthy, Subba R; Price, Kristin; Muzikansky, Alona; Hata, Aaron N; Heist, Rebecca S.
Afiliação
  • Dagogo-Jack I; Massachusetts General Hospital Cancer Center, Boston, Massachusetts; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
  • Moonsamy P; Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts.
  • Gainor JF; Massachusetts General Hospital Cancer Center, Boston, Massachusetts; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
  • Lennerz JK; Center for Integrated Diagnostics, Massachusetts General Hospital, Boston, Massachusetts.
  • Piotrowska Z; Massachusetts General Hospital Cancer Center, Boston, Massachusetts; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
  • Lin JJ; Massachusetts General Hospital Cancer Center, Boston, Massachusetts; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
  • Lennes IT; Massachusetts General Hospital Cancer Center, Boston, Massachusetts; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
  • Sequist LV; Massachusetts General Hospital Cancer Center, Boston, Massachusetts; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
  • Shaw AT; Massachusetts General Hospital Cancer Center, Boston, Massachusetts; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Novartis Institutes of Biomedical Research, Cambridge, Massachusetts.
  • Goodwin K; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Stevens SE; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Do A; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Digumarthy SR; Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts.
  • Price K; Guardant Health, Redwood City, California.
  • Muzikansky A; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
  • Hata AN; Massachusetts General Hospital Cancer Center, Boston, Massachusetts; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
  • Heist RS; Massachusetts General Hospital Cancer Center, Boston, Massachusetts; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: rheist@partners.org.
J Thorac Oncol ; 16(5): 850-859, 2021 05.
Article em En | MEDLINE | ID: mdl-33545388
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article